Suppr超能文献

缺失参与脂多糖核心和 O 抗原合成的基因对鼠伤寒沙门氏菌毒力和免疫原性的影响。

Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

机构信息

Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, Tempe, AZ 85287-5401, USA.

出版信息

Infect Immun. 2011 Oct;79(10):4227-39. doi: 10.1128/IAI.05398-11. Epub 2011 Jul 18.

Abstract

Lipopolysaccharide (LPS) is a major virulence factor of Salmonella enterica serovar Typhimurium and is composed of lipid A, core oligosaccharide (C-OS), and O-antigen polysaccharide (O-PS). While the functions of the gene products involved in synthesis of core and O-antigen have been elucidated, the effect of removing O-antigen and core sugars on the virulence and immunogenicity of Salmonella enterica serovar Typhimurium has not been systematically studied. We introduced nonpolar, defined deletion mutations in waaG (rfaG), waaI (rfaI), rfaH, waaJ (rfaJ), wbaP (rfbP), waaL (rfaL), or wzy (rfc) into wild-type S. Typhimurium. The LPS structure was confirmed, and a number of in vitro and in vivo properties of each mutant were analyzed. All mutants were significantly attenuated compared to the wild-type parent when administered orally to BALB/c mice and were less invasive in host tissues. Strains with ΔwaaG and ΔwaaI mutations, in particular, were deficient in colonization of Peyer's patches and liver. This deficiency could be partially overcome in the ΔwaaI mutant when it was administered intranasally. In the context of an attenuated vaccine strain delivering the pneumococcal antigen PspA, all of the mutations tested resulted in reduced immune responses against PspA and Salmonella antigens. Our results indicate that nonreversible truncation of the outer core is not a viable option for developing a live oral Salmonella vaccine, while a wzy mutant that retains one O-antigen unit is adequate for stimulating the optimal protective immunity to homologous or heterologous antigens by oral, intranasal, or intraperitoneal routes of administration.

摘要

脂多糖(LPS)是沙门氏菌血清型鼠伤寒的主要毒力因子,由脂质 A、核心寡糖(C-OS)和 O-抗原多糖(O-PS)组成。虽然涉及核心和 O-抗原合成的基因产物的功能已经阐明,但去除 O-抗原和核心糖对鼠伤寒沙门氏菌毒力和免疫原性的影响尚未得到系统研究。我们在野生型鼠伤寒沙门氏菌中引入了 waaG(rfaG)、waaI(rfaI)、rfaH、waaJ(rfaJ)、wbaP(rfbP)、waaL(rfaL)或 wzy(rfc)的非极性、定义缺失突变。确认了 LPS 结构,并分析了每个突变体的许多体外和体内特性。与野生型亲本相比,所有突变体在口服给予 BALB/c 小鼠时均显著减毒,并且在宿主组织中的侵袭性降低。与 ΔwaaG 和 ΔwaaI 突变株尤其缺乏在派尔集合淋巴结和肝脏中的定植能力。当通过鼻腔给予时,waaI 突变体的这种缺陷可以部分克服。在携带肺炎球菌抗原 PspA 的减毒疫苗株的背景下,测试的所有突变都导致针对 PspA 和沙门氏菌抗原的免疫反应降低。我们的结果表明,不可逆地截断外核心不是开发活口服沙门氏菌疫苗的可行选择,而保留一个 O-抗原单位的 wzy 突变体足以通过口服、鼻腔或腹腔途径刺激针对同源或异源抗原的最佳保护免疫。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验